>
Switch to:

Allergy Therapeutics Price-to-Operating-Cash-Flow

: 30.00 (As of Today)
View and export this data going back to 2004. Start your Free Trial

As of today (2021-12-01), Allergy Therapeutics's share price is $0.51. Allergy Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2021 was $0.02. Hence, Allergy Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is 30.00.

The historical rank and industry rank for Allergy Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

OTCPK:AGYTF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.92   Med: 17.5   Max: 61.5
Current: 29.58

5.92
61.5

During the past 13 years, Allergy Therapeutics's highest Price-to-Operating-Cash-Flow Ratio was 61.50. The lowest was 5.92. And the median was 17.50.

OTCPK:AGYTF's Price-to-Operating-Cash-Flow is ranked lower than
65% of the 710 Companies
in the Drug Manufacturers industry.

( Industry Median: 18.92 vs. OTCPK:AGYTF: 29.58 )

Allergy Therapeutics's Cash Flow from Operations per share for the six months ended in Jun. 2021 was $-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2021 was $0.02.


Allergy Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Allergy Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Price-to-Operating-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 17.50 7.37 20.83

Allergy Therapeutics Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Price-to-Operating-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.50 - 7.37 - 20.83

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Allergy Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Allergy Therapeutics Price-to-Operating-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Allergy Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Allergy Therapeutics's Price-to-Operating-Cash-Flow falls into.



Allergy Therapeutics Price-to-Operating-Cash-Flow Calculation

Allergy Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.51/0.017
=30.00

Allergy Therapeutics's Share Price of today is $0.51.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Allergy Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2021 was $0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Allergy Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergy Therapeutics Business Description

Allergy Therapeutics logo
Industry
Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)